Dáil Éireann Debate, Wednesday - 13 June 2012
232 Deputy Seán Kyne asked the Minister for Health the progress of the review process of the Health Service Executive regarding the introduction of Gilenya; and if an estimated time can be given for the introduction of same [28644/12]
View answerThe manufacturer of Fingolimod (Gilenya®) has submitted an application to the HSE for the product to be reimbursed through community pharmacies under the High-Tech Drug Scheme. The list of medicinal products provided under the High-Tech Drug Scheme is reviewed on a regular basis. The application in respect of the product in question is currently under consideration. The HSE hopes to finalise the review process as soon as possible.
